Analyzing the variance in protein expression profiles between patients diagnosed with idiopathic pulmonary fibrosis (IPF) and those with non-IPF interstitial lung diseases (ILD)

被引：0
|
作者：
Yen, Tsai-Hung [1 ]
Fu, Pin-Kuei [1 ]
机构：
[1] Taichung Vet Gen Hosp, Taichung, Taiwan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4254
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline
    Balestro, Elisabetta
    Castelli, Gioele
    Bernardinello, Nicol
    Cocconcelli, Elisabetta
    Biondini, Davide
    Fracasso, Federico
    Rea, Federico
    Saetta, Marina
    Baraldo, Simonetta
    Spagnolo, Paolo
    CHRONIC RESPIRATORY DISEASE, 2020, 17
  • [42] A Multivariable Protein-Inclusive Predictor of Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry
    Todd, J. L.
    Neely, M. L.
    Mulder, H.
    Lancaster, L. H.
    White, E. S.
    Hesslinger, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [43] Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms
    Karman, Jozsef
    Wang, Jing
    Bodea, Corneliu
    Cao, Sherry
    Levesque, Marc C.
    PLOS ONE, 2021, 16 (03):
  • [44] Epidemiology and mortality of non-idiopathic pulmonary fibrosis ( IPF) progressive fibrosing interstitial lung disease ( PF- ILD) using the French national health insurance system ( SNDS) database in France: the PROGRESS study
    Nasser, Mouhamad
    Larrieu, Sophie
    Boussel, Loic
    Si-Mohamed, Salim
    Diaz, Fabienne
    Marque, Sebastien
    Massol, Jacques
    Revel, Didier
    Thivolet-Bejui, Francoise
    Chalabreysse, Lara
    Maucort-Boulch, Delphine
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [45] Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
    Corte, Tamera J.
    Lancaster, Lisa
    Swigris, Jeffrey J.
    Maher, Toby M.
    Goldin, Jonathan G.
    Palmer, Scott M.
    Suda, Takafumi
    Ogura, Takashi
    Minnich, Anne
    Zhan, Xiaojiang
    Tirucherai, Giridhar S.
    Elpers, Brandon
    Xiao, Hong
    Watanabe, Hideaki
    Smith, R. Adam
    Charles, Edgar D.
    Fischer, Aryeh
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [46] THE SIGNIFICANCE OF KL-6, SP-D AND SP-A IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASES (CTD-ILDS)
    Yang, Junling
    Yan, Bingdi
    Zhang, Qinghua
    Zhao, Fenglian
    Ren, Jin
    RESPIROLOGY, 2015, 20 : 85 - 85
  • [47] The Detection of Acid and Non-Acid Reflux By Multichannel Intraluminal Impedance Testing (MII) in Idiopathic Pulmonary Fibrosis (IPF) Patients Being Evaluated for Lung Transplantation. a Prospective Study
    Pashinsky, Yevgenia
    Jaffin, Barry W.
    Goldstein, Eric S.
    Padilla, Maria L.
    GASTROENTEROLOGY, 2009, 136 (05) : A287 - A287
  • [48] International Classification of Functioning, Disability, and Health (ICF) Core Sets for Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) and Idiopathic Pulmonary Fibrosis (IPF) - a Necessary Map to Health Care Provision in the Era of ICD-11
    Escorpizo, Reuben
    Keen, Kevin J.
    Fligelstone, Kim
    Lammi, Matthew R.
    LeSage, Daphne
    Russell, Anne-Marie
    Birring, Surinder
    Sarver, Catherine
    Varga, Janos
    Distler, Oliver
    Saketkoo, Lesley Ann
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S318 - S318
  • [49] INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY, AND HEALTH (ICF) CORE SETS FOR CONNECTIVE TISSUE DISEASE INTERSTITIAL LUNG DISEASE (CTD-ILD) AND IDIOPATHIC PULMONARY FIBROSIS (IPF) - A NECESSARY MAP TO HEALTH CARE PROVISION IN THE ERA OF ICD-11
    Saketkoo, L. A.
    Escorpizo, R.
    Keen, K. J.
    Fligelstone, K.
    Birring, S. S.
    Lammi, M. R.
    Lasky, J. A.
    LeSage, D. R.
    Renzoni, E.
    Russell, A. M.
    Sarver, C.
    Scholand, M. B.
    Varga, J.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 599 - 599
  • [50] Prognostic value of 6-Min Walk Test (6MWT) in Patients with non-Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
    Jeanniard, Gregoire
    Nasser, Mouhamad
    Turquier, Segolene
    Ahmad, Kais
    Lopez, Jesus Calabuig
    Glerant, Jean-Charles
    Traclet, Julie
    Chambellan, Arnaud
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345